Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

CUSIP: 71722W107

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
78,837,943
Total 13F shares
30,786,694
Share change
+4,252,423
Total reported value
$219,689,484
Put/Call ratio
0.81%
Price per share
$7.14
Number of holders
83
Value change
+$28,315,357
Number of buys
48
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 71722W107?
CUSIP 71722W107 identifies PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q1 2023

As of 31 Mar 2023, Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,786,694 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., Carlyle Group Inc., Medicxi Ventures Management (Jersey) Ltd, Invesco Ltd., Avidity Partners Management LP, Ensign Peak Advisors, Inc, BlackRock Inc., 683 Capital Management, LLC, VANGUARD GROUP INC, and Newtyn Management, LLC. This page lists 83 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.